Combining Gene Expression Profiles and Clinical Parameters for Risk Stratification in Medulloblastomas

Abstract excerpt

PURPOSE: Stratification of risk in patients with medulloblastoma remains a challenge. As clinical parameters have been proven insufficient for accurately defining disease risk, molecular markers have become the focus of interest. Outcome predictions on the basis of microarray gene expression profiles have been the most accurate to date. We ask in a multivariate model whether clinical parameters enhance survival...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Ferroptosis and cancer prognosis
• Share to Glioma Diagnosis and Treatment
• Share to TGF-β signaling in diseases